title: Daglutril for treatment of renal damage in hypertensive patients with type 2 diabetes: disappointment or hope?
authors.affiliation: Department of Pharmacology and INSERM U970, Université Paris Descartes, 75015 Paris, France; Hôpital Européen Georges Pompidou, Université Paris Descartes, 75015 Paris, France; Assistance Publique-Hôpitaux de Paris, Université Paris Descartes, 75015 Paris, France. Electronic address: stephane.laurent@egp.aphp.fr.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Laurent
mesh_terms: D000419:Albuminuria / Q000188:drug therapy*; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors*; D001552:Benzazepines / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000072396:Endothelin-Converting Enzymes; D005260:Female; D006801:Humans; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D015260:Neprilysin / Q000037:antagonists & inhibitors*
chemical_list: D001552:Benzazepines; C405520:SLV 306; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; D015260:Neprilysin; D000072396:Endothelin-Converting Enzymes